In November of 2013, the National Coalition of STD Directors (NCSD) and its Members passed a policy statement that calls on partners within the diagnostic community, public health agencies and regulatory bodies to move swiftly to make an RST as outlined above be commercially available in the United States.
In November of 2013, NCSD members passed a policy statement that urges federal, state and local public health officials, researchers and industry partners to collaborate to bring rapid molecular antimicrobial susceptibility testing for gonorrhea to the market to benefit individual and public health.
In September 2012, NCSD and NASTAD released a statement that calls on state health departments to take six immediate steps to reduce an HIV epidemic that continues to disproportionately impact gay men/MSM, especially Black and Latino gay men/MSM.
In October 2010, NCSD released a statement on the lack of sufficient STD/HIV prevention efforts within the adult film industry, urging national regulation of the industry and highlighting the need for multifaceted efforts to ensure enforcement.
In June 2010, NCSD and the National Alliance of State and Territoral AIDS Directors (NASTAD) issued a joint statement of urgency on the increasingly disproportionate toll of HIV and STDs on gay and bisexual men.